- Home
- SPRU vs MRSN Comparison
SPRU vs MRSN Comparison
Compare SPRU & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- MRSN
- Stock Information
- Founded
- SPRU 2008
- MRSN 2001
- Country
- SPRU United States
- MRSN United States
- Employees
- SPRU N/A
- MRSN N/A
- Industry
- SPRU Auto Parts:O.E.M.
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- MRSN Health Care
- Exchange
- SPRU Nasdaq
- MRSN Nasdaq
- Market Cap
- SPRU 34.9M
- MRSN 40.7M
- IPO Year
- SPRU N/A
- MRSN 2017
- Fundamental
- Price
- SPRU $1.99
- MRSN $0.36
- Analyst Decision
- SPRU
- MRSN Strong Buy
- Analyst Count
- SPRU 0
- MRSN 5
- Target Price
- SPRU N/A
- MRSN $5.75
- AVG Volume (30 Days)
- SPRU 46.5K
- MRSN 2.3M
- Earning Date
- SPRU 08-13-2025
- MRSN 08-12-2025
- Dividend Yield
- SPRU N/A
- MRSN N/A
- EPS Growth
- SPRU N/A
- MRSN N/A
- EPS
- SPRU N/A
- MRSN N/A
- Revenue
- SPRU $87,638,000.00
- MRSN $34,006,000.00
- Revenue This Year
- SPRU $2.12
- MRSN N/A
- Revenue Next Year
- SPRU N/A
- MRSN $1.30
- P/E Ratio
- SPRU N/A
- MRSN N/A
- Revenue Growth
- SPRU 9.48
- MRSN N/A
- 52 Week Low
- SPRU $1.42
- MRSN $0.26
- 52 Week High
- SPRU $3.68
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- SPRU 55.21
- MRSN 46.82
- Support Level
- SPRU $1.82
- MRSN $0.35
- Resistance Level
- SPRU $1.99
- MRSN $0.39
- Average True Range (ATR)
- SPRU 0.11
- MRSN 0.03
- MACD
- SPRU 0.01
- MRSN -0.00
- Stochastic Oscillator
- SPRU 54.55
- MRSN 12.30
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.